277 related articles for article (PubMed ID: 14534785)
1. Reproducibility of the 1998 World Health Organization/International Society of Urologic Pathology classification of papillary urothelial neoplasms of the urinary bladder.
Yorukoglu K; Tuna B; Dikicioglu E; Duzcan E; Isisag A; Sen S; Mungan U; Kirkali Z
Virchows Arch; 2003 Dec; 443(6):734-40. PubMed ID: 14534785
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system.
Miyamoto H; Miller JS; Fajardo DA; Lee TK; Netto GJ; Epstein JI
Pathol Int; 2010 Jan; 60(1):1-8. PubMed ID: 20055945
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
[TBL] [Abstract][Full Text] [Related]
4. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results.
Curry JL; Wojcik EM
Cancer; 2002 Jun; 96(3):140-5. PubMed ID: 12115301
[TBL] [Abstract][Full Text] [Related]
5. Urothelial neoplasia of the urinary bladder--comparison of interobserver variability for WHO Classification 1972 with WHO/ISUP Consensus Classification 1998.
Mamoon N; Iqbal MA; Jamal S; Luqman M
J Ayub Med Coll Abbottabad; 2006; 18(2):4-8. PubMed ID: 16977804
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 1998 WHO/ISUP and 1973 WHO classifications for interobserver variability in grading of papillary urothelial neoplasms of the bladder. Pathological evaluation of 258 cases.
Gonul II; Poyraz A; Unsal C; Acar C; Alkibay T
Urol Int; 2007; 78(4):338-44. PubMed ID: 17495493
[TBL] [Abstract][Full Text] [Related]
7. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up.
Yin H; Leong AS
Am J Clin Pathol; 2004 May; 121(5):679-87. PubMed ID: 15151208
[TBL] [Abstract][Full Text] [Related]
8. Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome.
Campbell PA; Conrad RJ; Campbell CM; Nicol DL; MacTaggart P
BJU Int; 2004 Jun; 93(9):1228-31. PubMed ID: 15180612
[TBL] [Abstract][Full Text] [Related]
9. Histologic grading of urothelial carcinoma: a reappraisal.
Cheng L; MacLennan GT; Lopez-Beltran A
Hum Pathol; 2012 Dec; 43(12):2097-108. PubMed ID: 22542126
[TBL] [Abstract][Full Text] [Related]
10. Histologic grading of urothelial papillary neoplasms: impact of combined grading (two-numbered grading system) on reproducibility.
Tuna B; Yörükoglu K; Düzcan E; Sen S; Nese N; Sarsık B; Akder A; Sayhan S; Mungan U; Kirkali Z
Virchows Arch; 2011 Jun; 458(6):659-64. PubMed ID: 21484429
[TBL] [Abstract][Full Text] [Related]
11. Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.
Miyamoto H; Brimo F; Schultz L; Ye H; Miller JS; Fajardo DA; Lee TK; Epstein JI; Netto GJ
Arch Pathol Lab Med; 2010 Aug; 134(8):1160-3. PubMed ID: 20670136
[TBL] [Abstract][Full Text] [Related]
12. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.
Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI
J Urol; 2005 Nov; 174(5):1976-80. PubMed ID: 16217372
[TBL] [Abstract][Full Text] [Related]
13. The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement?
Epstein JI
Crit Rev Oncol Hematol; 2003 Aug; 47(2):83-9. PubMed ID: 12900003
[TBL] [Abstract][Full Text] [Related]
14. Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems.
Oosterhuis JW; Schapers RF; Janssen-Heijnen ML; Pauwels RP; Newling DW; ten Kate F
J Clin Pathol; 2002 Dec; 55(12):900-5. PubMed ID: 12461053
[TBL] [Abstract][Full Text] [Related]
15. Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification.
Whisnant RE; Bastacky SI; Ohori NP
Diagn Cytopathol; 2003 Apr; 28(4):186-90. PubMed ID: 12672093
[TBL] [Abstract][Full Text] [Related]
16. Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016".
Compérat EM; Burger M; Gontero P; Mostafid AH; Palou J; Rouprêt M; van Rhijn BWG; Shariat SF; Sylvester RJ; Zigeuner R; Babjuk M
Eur Urol Focus; 2019 May; 5(3):457-466. PubMed ID: 29366854
[TBL] [Abstract][Full Text] [Related]
17. How to Name Papillary Tumors of the Bladder in Children: Transitional Cell Carcinoma or Papillary Urothelial Neoplasm of Low Malignant Potential?
Umlauf VN; Coerdt W; Leuschner I; Schröder A; Stein R; Beetz R
Urology; 2015 Aug; 86(2):379-83. PubMed ID: 26169007
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.
Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM
Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527
[TBL] [Abstract][Full Text] [Related]
19. Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems.
Schned AR; Andrew AS; Marsit CJ; Zens MS; Kelsey KT; Karagas MR
J Urol; 2007 Oct; 178(4 Pt 1):1196-200; discussion 1200. PubMed ID: 17698105
[TBL] [Abstract][Full Text] [Related]
20. Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy.
Holmäng S; Andius P; Hedelin H; Wester K; Busch C; Johansson SL
J Urol; 2001 Apr; 165(4):1124-8; discussion 1128-30. PubMed ID: 11257652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
